Skip survey header

Severe Asthma Research Study Seeks Participants

Consent to Continue

After completing this brief questionnaire, more detailed information will be given to you before you decide whether or not to take part in the research, and you will have the opportunity to speak with and ask questions to a study coordinator. You can stop this discussion at any time.
Please note that by completing this questionnaire, you consent to Trialfacts collecting your answers to the questions, including your contact information.  All information you provide in this questionnaire will be held in strict confidence, and shared only with the research center conducting the study. Trialfacts will delete your information from our records upon your request. While completing the questionnaire you will have the option to join our mailing list to be contacted via email about future clinical trials for which you may be eligible. Trialfacts may also reach out to you to gather feedback around your experience with us. You will not be contacted about future trials if you choose not to sign up to our mailing list.

For your reference, please find a link to the Trialfacts Privacy Policy.
Please note:
Due to the current situation with COVID-19 pandemic, the study team would like to point out the following:
  • The research site does not treat patients with active or suspected COVID-19.  
  • The research site’s waiting area is spacious enough that participants will not be within close proximity to each other.
  • Hand sanitizers are available at the research site.
  • Study participants are required to wear a face mask at all times during their visit.
  • The research staff adheres to the CDC guidelines and strict hygienic practices as well as other safety measures to prevent the spread of COVID-19. 
  • To prioritize the participants’ and the study team’s health, the research site is taking all precautionary measures for COVID-19. These precautionary rules and guidelines are site specific. The study team can explain further on this.

Are you willing to continue? *This question is required.